3rd Quarter - Report

ONCOLOGY NURSING SOCIETY for ONCOLOGY NURSING SOCIETY

Period 3rd Quarter 2018 Filed Oct 18, 2018 Signed by Michele McCorkle

Official filing
Firm
ONCOLOGY NURSING SOCIETY
Client
ONCOLOGY NURSING SOCIETY
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitoring healthcare regulations and legislation; Palliative Care Hospice Education and Treatment Act PCHETA (H.R. 1676/S. 693); Oral Cancer Drug Parity Act (H.R. 1409);Title VIII Nursing Workforce Reauthorization Act (H.R. 959; Lymphedema Treatment Act (HR 930, S497); Cancer Communications and Planning Act (HR 5160)

LobbyistCovered position, as disclosed
ALEC STONE Clinton White House, Women's Health Initiatives
DONNA SLINGLUFF SWEENEY New —

Contacted: Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1676 (115th), H.R. 930 (115th), H.R. 5160 (115th), H.R. 1409 (115th), S. 693 (115th), H.R. 959 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.